264 related articles for article (PubMed ID: 19751880)
1. Sebaceous lesions and their associated syndromes: part II.
Eisen DB; Michael DJ
J Am Acad Dermatol; 2009 Oct; 61(4):563-78; quiz 579-80. PubMed ID: 19751880
[TBL] [Abstract][Full Text] [Related]
2. Sebaceous lesions and their associated syndromes: part I.
Eisen DB; Michael DJ
J Am Acad Dermatol; 2009 Oct; 61(4):549-60; quiz 561-2. PubMed ID: 19751879
[TBL] [Abstract][Full Text] [Related]
3. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
[TBL] [Abstract][Full Text] [Related]
4. Muir-Torre syndrome.
Cohen PR; Kohn SR; Davis DA; Kurzrock R
Dermatol Clin; 1995 Jan; 13(1):79-89. PubMed ID: 7712655
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
Abbas O; Mahalingam M
J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
[TBL] [Abstract][Full Text] [Related]
6. Muir-Torre syndrome: a case report and review of the literature.
Pettey AA; Walsh JS
Cutis; 2005 Mar; 75(3):149-55. PubMed ID: 15839358
[TBL] [Abstract][Full Text] [Related]
7. Muir-Torre syndrome.
Ponti G; Ponz de Leon M
Lancet Oncol; 2005 Dec; 6(12):980-7. PubMed ID: 16321766
[TBL] [Abstract][Full Text] [Related]
8. Muir-Torre syndrome: Diagnostic and screening guidelines.
Jones B; Oh C; Mangold E; Egan CA
Australas J Dermatol; 2006 Nov; 47(4):266-9. PubMed ID: 17034469
[TBL] [Abstract][Full Text] [Related]
9. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].
Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V
Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166
[TBL] [Abstract][Full Text] [Related]
10. Sebaceous gland adenoma of the tarsal conjunctiva in a patient with Muir-Torre syndrome.
Font RL; Rishi K
Ophthalmology; 2003 Sep; 110(9):1833-6. PubMed ID: 13129885
[TBL] [Abstract][Full Text] [Related]
11. [Torre-Muir syndrome. Sebaceous gland neoplasms, keratoacanthomas, multiple internal cancers and heredity].
Worret WI; Burgdorf WH; Fahmy A; Pitha J
Hautarzt; 1981 Oct; 32(10):519-24. PubMed ID: 7298331
[TBL] [Abstract][Full Text] [Related]
12. The Muir-Torre syndrome: a 25-year retrospect.
Schwartz RA; Torre DP
J Am Acad Dermatol; 1995 Jul; 33(1):90-104. PubMed ID: 7601953
[TBL] [Abstract][Full Text] [Related]
13. Muir-Torre syndrome: clinical features and molecular genetic analysis.
Esche C; Kruse R; Lamberti C; Friedl W; Propping P; Lehmann P; Ruzicka T
Br J Dermatol; 1997 Jun; 136(6):913-7. PubMed ID: 9217825
[TBL] [Abstract][Full Text] [Related]
14. Universal immunohistochemical screening of sebaceous neoplasms for Muir-Torre syndrome: Putting the cart before the horse?
Kim RH; Nagler AR; Meehan SA
J Am Acad Dermatol; 2016 Nov; 75(5):1078-1079. PubMed ID: 27745640
[No Abstract] [Full Text] [Related]
15. Different phenotypes in Muir-Torre syndrome: clinical and biomolecular characterization in two Italian families.
Ponti G; Ponz de Leon M; Losi L; Di Gregorio C; Benatti P; Pedroni M; Scarselli A; Riegler G; Lembo L; Pellacani G; Seidenari S; Rossi G; Roncucci L
Br J Dermatol; 2005 Jun; 152(6):1335-8. PubMed ID: 15949004
[TBL] [Abstract][Full Text] [Related]
16. An illustrative case of Muir-Torre syndrome: contribution of immunohistochemical analysis in identifying indicator sebaceous lesions.
Marazza G; Masouyé I; Taylor S; Prins C; Gaudin T; Saurat JH; French LE
Arch Dermatol; 2006 Aug; 142(8):1039-42. PubMed ID: 16924054
[TBL] [Abstract][Full Text] [Related]
17. Considerations on the performance of immunohistochemistry for mismatch repair gene proteins in cases of sebaceous neoplasms and keratoacanthomas with reference to Muir-Torre syndrome.
Fernandez-Flores A
Am J Dermatopathol; 2012 Jun; 34(4):416-22. PubMed ID: 22123265
[TBL] [Abstract][Full Text] [Related]
18. Sebaceous neoplasms with mismatch repair protein expressions and the frequency of co-existing visceral tumors.
Lee BA; Yu L; Ma L; Lind AC; Lu D
J Am Acad Dermatol; 2012 Dec; 67(6):1228-34. PubMed ID: 22552002
[TBL] [Abstract][Full Text] [Related]
19. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients.
Harwood CA; Swale VJ; Bataille VA; Quinn AG; Ghali L; Patel SV; Dove-Edwin I; Cerio R; McGregor JM
J Invest Dermatol; 2001 Feb; 116(2):246-53. PubMed ID: 11180000
[TBL] [Abstract][Full Text] [Related]
20. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome.
Roberts ME; Riegert-Johnson DL; Thomas BC; Rumilla KM; Thomas CS; Heckman MG; Purcell JU; Hanson NB; Leppig KA; Lim J; Cappel MA
Genet Med; 2014 Sep; 16(9):711-6. PubMed ID: 24603434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
